Abstract:Asymmetric propargylic substitution (APS) reactions play a crucial role in synthesizing the fundamental structural units found in natural drug molecules and macromolecules. However, achieving both high yields and enantioselectivity in the synthesis of asymmetric alkynyl propyl compounds remains a formidable challenge. In this study, we present a comprehensive computational study of asymmetric alkynyl propyl hydroxyaminations catalyzed by a chiral phosphine-nickel complex. The entire catalysis can be outlined as three stages: (i) Propargylic carbonate 1a activation by the (S)-L1/Ni(0)-catalyst, results in the Ni(II)-intermediate IM2A. (ii) IM2A undergoes decarboxylation process, leading to the Ni(II)-complex IM5A. (iii) IM5A suffers asymmetric propargylic substitution with N-hydroxyphthalimide 2a gives the more stable Ni(0)-complex IM7A, followed by product (S)-3a liberation and IM1A regeneration for the next catalytic cycle with the assistance of another equiv 1a. The asymmetric propargylic substitution step, with a barrier of 21.4 kcal/mol, should be the rate-determining step and enantioselectivity-determining step during the whole catalysis. EDA-NOCV analysis revealed that the origins of the enantioselectivity of product (S)-3a lies in the combination effects of the ligand-substrate electrostatic interactions, orbital interactions, Pauli repulsions, and dispersion interactions. Based on mechanistic study, new biaryl bisphosphine ligand (i.e., (S)-L6) affording higher enantioselectivity was designed, which will help to improve current catalytic systems and facilitate the development of new Ni-catalyzed asymmetric alkynyl propyl hydroxyaminations.

Nickel-Catalyzed Enantioselective Hydrophosphinylation of 2-Azadienes to Access Enantioenriched -Aminophosphine Oxides

Nickel-Catalyzed Enantioselective Hydrophosphinylation of 2-Azadienes to Access Enantioenriched α-Aminophosphine Oxides

Asymmetric Synthesis Xxviii: Novel Chiral Aminophosphine Phosphinite Ligand And Its Application In Homogeneous Catalytic Asymmetric Hydrogenation Of Dehydroamino Acid Derivatives

Nickel-Catalyzed Atroposelective C-H Alkylation Enabled by Bimetallic Catalysis with Air-Stable Heteroatom-Substituted Secondary Phosphine Oxide Preligands

Nickel-Catalyzed Enantioselective Alkylation of Primary Phosphines

Enantioselective Hydrophosphination of Terminal Alkenyl Aza-Heteroarenes

Catalytic Asymmetric Hydrophosphinylation of 2‐Vinylazaarenes to Access P‐Chiral 2‐Azaaryl‐Ethylphosphine Oxides

Ni-Catalyzed Asymmetric Hydrogenation of Α-Substituted Α,β-Unsaturated Phosphine Oxides/Phosphonates/Phosphoric Acids.

A Computational mechanistic study on the Ni-Catalyzed Asymmetric Alkynyl Propyl Hydroxyaminations: Origin of Enantioselectivity and Further Rational Design

Nickel-Catalyzed Asymmetric Synthesis of P-Stereogenic Phosphanyl Hydrazine Building Blocks

Catalytic Asymmetric Hydrophosphinylation of Alpha,Beta-Unsaturated N-Acylpyrroles: Application of Dialkyl Phosphine Oxides in Enantioselective Synthesis of Chiral Phosphine Oxides or Phosphines

Synthesis of P-Stereogenic Phosphinamides Via Pd(II)-Catalyzed Enantioselective C-H Alkynylation

Nickel-catalyzed Switchable 1,3-Dienylation and Enantioselective Allenylation of Phosphine Oxides.

Stereospecific nickel-catalyzed [4+2] heteroannulation of alkynes with aminophosphanes

Catalytic Asymmetric Three-Component Reaction of 2-Alkynylbenzaldehydes, Amines, and Dimethylphosphonate

Ni-Catalyzed Asymmetric Hydrophosphination of Unactivated Alkynes

Pd(II)-Catalyzed Enantioselective C-H Olefination Toward the Synthesis of P-stereogenic Phosphinamides.

Synthesis of P-Stereogenic Phosphinamides via Nickel-Catalyzed Kinetic Resolution of H-Phosphinamides by Alkenylation and Arylation

Ni II -Catalyzed Enantioselective Anti -Markovnikov Hydrophosphination of Unactivated Alkynes

Efficient Asymmetric Synthesis of P-chiral Phosphine Oxides Via Properly Designed and Activated Benzoxazaphosphinine-2-oxide Agents.

Highly enantioselective phosphination and hydrophosphonylation of azomethine imines: using chiral squaramide as a hydrogen bonding organocatalyst.